Investments
Teva Undercuts Its 50-Day Line On Flat Sales As Profit Misses Forecasts
Generic drugs behemoth Teva Pharmaceutical (TEVA) reported light profit and flat sales Wednesday, and TEVA stock tumbled. During the March quarter, Teva earned an adjusted 40 cents per share on $3.66 billion in sales. Teva’s […]